Serum estrone concentration, estrone sulfate/estrone ratio and BMI are associated with human epidermal growth factor receptor 2 and progesterone receptor status in postmenopausal primary breast cancer patients suffering invasive ductal carcinoma
BACKGROUND: We investigated in postmenopausal women with primary breast cancer prior to surgical intervention whether, serum levels of different steroid hormones and hormonal precursors associated with tumor tissue estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520825/ https://www.ncbi.nlm.nih.gov/pubmed/26240785 http://dx.doi.org/10.1186/s40064-015-1171-8 |
_version_ | 1782383714094809088 |
---|---|
author | Vincze, Borbála Kapuvári, Bence Udvarhelyi, Nóra Horváth, Zsolt Mátrai, Zoltán Czeyda-Pommersheim, Ferenc Kőhalmy, Krisztina Kovács, Judit Boldizsár, Mariann Láng, István Kásler, Miklós |
author_facet | Vincze, Borbála Kapuvári, Bence Udvarhelyi, Nóra Horváth, Zsolt Mátrai, Zoltán Czeyda-Pommersheim, Ferenc Kőhalmy, Krisztina Kovács, Judit Boldizsár, Mariann Láng, István Kásler, Miklós |
author_sort | Vincze, Borbála |
collection | PubMed |
description | BACKGROUND: We investigated in postmenopausal women with primary breast cancer prior to surgical intervention whether, serum levels of different steroid hormones and hormonal precursors associated with tumor tissue estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) status. METHODS: We enrolled 1,042 patients suffering invasive ductal carcinoma undergoing surgical resection in the National Institute of Oncology, Hungary between 2003 and 2011. Serum parameters were measured by RIA/IRMA assays; tumor tissue ER, PR and HER2 status was assessed histologically. Patients were classified according to tumor receptor status. Case–case analysis subjects were categorized into four subgroups based on serum hormone concentrations in ER, PR and HER2 receptor-negative cases, respectively. RESULTS: Serum estrone sulfate and dehydroepiandrosterone sulfate levels correlated with each other and also with serum estrone and estradiol levels. According to case–case study the odds ratios in the highest quartile were 1.517 (p = 0.0305, P(trend) = 0.0394) for androstenedione, 1.495 (p = 0.0317, P(trend) < 0.0105) for estrone and 0.654 (p = 0.0273, P(trend) < 0.0151) for estrone sulfate/estrone ratio in PR+ vs. PR− tumors. Regarding HER2 status (HER2+ vs. HER2−), the odds ratios for estrone, estrone sulfate and estrone sulfate/estrone ratio were 0.530 (p = 0.0234, P(trend) = 0.0595), 2.438 (p = 0.0042, P(trend) < 0.0066) and 3.118 (p = 0.0001, P(trend) < 0.0001) in the highest quartile, respectively. Of note significantly increased BMI associates with PR+ and ER +/PR+ status while significantly decreased BMI was observed in HER2+ cases. CONCLUSIONS: Taken together, measurement of serum estrone and estrone sulfate concentrations prior to surgical intervention might support the individualization of regime in postmenopausal primary breast cancer patients. |
format | Online Article Text |
id | pubmed-4520825 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-45208252015-08-03 Serum estrone concentration, estrone sulfate/estrone ratio and BMI are associated with human epidermal growth factor receptor 2 and progesterone receptor status in postmenopausal primary breast cancer patients suffering invasive ductal carcinoma Vincze, Borbála Kapuvári, Bence Udvarhelyi, Nóra Horváth, Zsolt Mátrai, Zoltán Czeyda-Pommersheim, Ferenc Kőhalmy, Krisztina Kovács, Judit Boldizsár, Mariann Láng, István Kásler, Miklós Springerplus Research BACKGROUND: We investigated in postmenopausal women with primary breast cancer prior to surgical intervention whether, serum levels of different steroid hormones and hormonal precursors associated with tumor tissue estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) status. METHODS: We enrolled 1,042 patients suffering invasive ductal carcinoma undergoing surgical resection in the National Institute of Oncology, Hungary between 2003 and 2011. Serum parameters were measured by RIA/IRMA assays; tumor tissue ER, PR and HER2 status was assessed histologically. Patients were classified according to tumor receptor status. Case–case analysis subjects were categorized into four subgroups based on serum hormone concentrations in ER, PR and HER2 receptor-negative cases, respectively. RESULTS: Serum estrone sulfate and dehydroepiandrosterone sulfate levels correlated with each other and also with serum estrone and estradiol levels. According to case–case study the odds ratios in the highest quartile were 1.517 (p = 0.0305, P(trend) = 0.0394) for androstenedione, 1.495 (p = 0.0317, P(trend) < 0.0105) for estrone and 0.654 (p = 0.0273, P(trend) < 0.0151) for estrone sulfate/estrone ratio in PR+ vs. PR− tumors. Regarding HER2 status (HER2+ vs. HER2−), the odds ratios for estrone, estrone sulfate and estrone sulfate/estrone ratio were 0.530 (p = 0.0234, P(trend) = 0.0595), 2.438 (p = 0.0042, P(trend) < 0.0066) and 3.118 (p = 0.0001, P(trend) < 0.0001) in the highest quartile, respectively. Of note significantly increased BMI associates with PR+ and ER +/PR+ status while significantly decreased BMI was observed in HER2+ cases. CONCLUSIONS: Taken together, measurement of serum estrone and estrone sulfate concentrations prior to surgical intervention might support the individualization of regime in postmenopausal primary breast cancer patients. Springer International Publishing 2015-07-31 /pmc/articles/PMC4520825/ /pubmed/26240785 http://dx.doi.org/10.1186/s40064-015-1171-8 Text en © Vincze et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Vincze, Borbála Kapuvári, Bence Udvarhelyi, Nóra Horváth, Zsolt Mátrai, Zoltán Czeyda-Pommersheim, Ferenc Kőhalmy, Krisztina Kovács, Judit Boldizsár, Mariann Láng, István Kásler, Miklós Serum estrone concentration, estrone sulfate/estrone ratio and BMI are associated with human epidermal growth factor receptor 2 and progesterone receptor status in postmenopausal primary breast cancer patients suffering invasive ductal carcinoma |
title | Serum estrone concentration, estrone sulfate/estrone ratio and BMI are associated with human epidermal growth factor receptor 2 and progesterone receptor status in postmenopausal primary breast cancer patients suffering invasive ductal carcinoma |
title_full | Serum estrone concentration, estrone sulfate/estrone ratio and BMI are associated with human epidermal growth factor receptor 2 and progesterone receptor status in postmenopausal primary breast cancer patients suffering invasive ductal carcinoma |
title_fullStr | Serum estrone concentration, estrone sulfate/estrone ratio and BMI are associated with human epidermal growth factor receptor 2 and progesterone receptor status in postmenopausal primary breast cancer patients suffering invasive ductal carcinoma |
title_full_unstemmed | Serum estrone concentration, estrone sulfate/estrone ratio and BMI are associated with human epidermal growth factor receptor 2 and progesterone receptor status in postmenopausal primary breast cancer patients suffering invasive ductal carcinoma |
title_short | Serum estrone concentration, estrone sulfate/estrone ratio and BMI are associated with human epidermal growth factor receptor 2 and progesterone receptor status in postmenopausal primary breast cancer patients suffering invasive ductal carcinoma |
title_sort | serum estrone concentration, estrone sulfate/estrone ratio and bmi are associated with human epidermal growth factor receptor 2 and progesterone receptor status in postmenopausal primary breast cancer patients suffering invasive ductal carcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520825/ https://www.ncbi.nlm.nih.gov/pubmed/26240785 http://dx.doi.org/10.1186/s40064-015-1171-8 |
work_keys_str_mv | AT vinczeborbala serumestroneconcentrationestronesulfateestroneratioandbmiareassociatedwithhumanepidermalgrowthfactorreceptor2andprogesteronereceptorstatusinpostmenopausalprimarybreastcancerpatientssufferinginvasiveductalcarcinoma AT kapuvaribence serumestroneconcentrationestronesulfateestroneratioandbmiareassociatedwithhumanepidermalgrowthfactorreceptor2andprogesteronereceptorstatusinpostmenopausalprimarybreastcancerpatientssufferinginvasiveductalcarcinoma AT udvarhelyinora serumestroneconcentrationestronesulfateestroneratioandbmiareassociatedwithhumanepidermalgrowthfactorreceptor2andprogesteronereceptorstatusinpostmenopausalprimarybreastcancerpatientssufferinginvasiveductalcarcinoma AT horvathzsolt serumestroneconcentrationestronesulfateestroneratioandbmiareassociatedwithhumanepidermalgrowthfactorreceptor2andprogesteronereceptorstatusinpostmenopausalprimarybreastcancerpatientssufferinginvasiveductalcarcinoma AT matraizoltan serumestroneconcentrationestronesulfateestroneratioandbmiareassociatedwithhumanepidermalgrowthfactorreceptor2andprogesteronereceptorstatusinpostmenopausalprimarybreastcancerpatientssufferinginvasiveductalcarcinoma AT czeydapommersheimferenc serumestroneconcentrationestronesulfateestroneratioandbmiareassociatedwithhumanepidermalgrowthfactorreceptor2andprogesteronereceptorstatusinpostmenopausalprimarybreastcancerpatientssufferinginvasiveductalcarcinoma AT kohalmykrisztina serumestroneconcentrationestronesulfateestroneratioandbmiareassociatedwithhumanepidermalgrowthfactorreceptor2andprogesteronereceptorstatusinpostmenopausalprimarybreastcancerpatientssufferinginvasiveductalcarcinoma AT kovacsjudit serumestroneconcentrationestronesulfateestroneratioandbmiareassociatedwithhumanepidermalgrowthfactorreceptor2andprogesteronereceptorstatusinpostmenopausalprimarybreastcancerpatientssufferinginvasiveductalcarcinoma AT boldizsarmariann serumestroneconcentrationestronesulfateestroneratioandbmiareassociatedwithhumanepidermalgrowthfactorreceptor2andprogesteronereceptorstatusinpostmenopausalprimarybreastcancerpatientssufferinginvasiveductalcarcinoma AT langistvan serumestroneconcentrationestronesulfateestroneratioandbmiareassociatedwithhumanepidermalgrowthfactorreceptor2andprogesteronereceptorstatusinpostmenopausalprimarybreastcancerpatientssufferinginvasiveductalcarcinoma AT kaslermiklos serumestroneconcentrationestronesulfateestroneratioandbmiareassociatedwithhumanepidermalgrowthfactorreceptor2andprogesteronereceptorstatusinpostmenopausalprimarybreastcancerpatientssufferinginvasiveductalcarcinoma |